Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: BT-114143 Injection · Abnormal Uterine Bleeding Primary completion pushed from Sep 23, 2025 to Apr 28, 2026
- Notable: Paediatric Sleep Diagnosis Technology Primary and study completion dates pushed to Oct 14, 2027
- Notable: NeVa Retrospective Comparative SR Study Primary and study completion dates pushed to Feb 1, 2027
- Notable: Neuralert Stroke Monitor Pilot Trial Primary completion pushed from May 1, 2026 to Nov 14, 2027
- Notable: KPAP vs EPR for Comfort Primary completion pushed from Dec 1, 2026 to Jul 1, 2027
- Notable: KPAP vs AirSense 11 With EPR Primary completion pushed from Feb 1, 2027 to Dec 1, 2027
- Notable: Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen · Adults and Adolescents With Tuberculous Meningitis Primary completion pushed from Apr 30, 2028 to Oct 1, 2029
- Notable: Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil Primary completion pushed from May 30, 2026 to Dec 30, 2026
- Notable: Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial Primary completion pushed from Nov 1, 2026 to Mar 15, 2029
- Notable: PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System Primary completion pushed from Jul 1, 2027 to Aug 1, 2028
- Notable: Vancomycin Taper to Prevent Recurrent Clostridioides Difficile Primary completion pushed from Jun 1, 2030 to Jul 1, 2031
- Notable: Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment · Metastatic (Stage IV) Breast Cancer Primary completion pushed from Jul 31, 2026 to Nov 30, 2027
- Notable: Anticoagulation in Post MI LV Thrombus Trial in Nepal Primary and study completion dates pushed to Dec 2028
- Notable: Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma Primary completion pushed from Jul 30, 2026 to Dec 30, 2027
- Notable: Reduced Venetoclax Exposure Primary completion pushed from Oct 2026 to Oct 2027
- Notable: Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery Primary and study completion dates pushed to Jun 2029
- Notable: Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer Primary completion pushed from Dec 2025 to Dec 1, 2027
- Notable: Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases Primary completion pushed from Apr 1, 2027 to Dec 20, 2027
- Notable: Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer Primary completion pushed from Jul 2026 to Jul 1, 2027
- Notable: Combining Stellate Ganglion Block With Prolonged Exposure for PTSD Primary completion pushed from Mar 31, 2027 to Mar 31, 2028
- Notable: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Primary completion pushed from May 31, 2024 to Feb 15, 2025
- Notable: Optimization of Post-transplantation Benadamustine and Cyclophosphamide · High-risk Myeloid Malignancies and a Partially Mismatched Donor Primary and study completion pushed from Dec 10, 2026 to Dec 10, 2027
- Notable: [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression · Metastatic Breast Cancer Primary completion pushed from Dec 31, 2027 to Dec 31, 2028
- Notable: Treatment of Social and Language Deficits With Leucovorin for Young · Autism Primary and study completion pushed from Jul 31, 2026 to Jan 31, 2027
- Notable: Ketamine for Combined Depression and Alcohol Use Disorder Primary and study completion pushed from Jul 1, 2027 to Jul 1, 2028
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates